欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/2249/001
药品名称Terbinafin Moberg Pharma
活性成分
    • terbinafine hydrochloride 98.0 mg/ml
剂型Cutaneous solution
上市许可持有人Moberg Pharma AB, Sweden
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Ireland (IE)
    • Austria (AT)
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Norway (NO)
    • Finland (FI)
    • Hungary (HU)
    • Czechia (CZ)
      Terbinafine Moberg Pharma
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
许可日期2023/06/27
最近更新日期2024/09/17
药物ATC编码
    • D01AE15 terbinafine
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Non Prescription (including OTC)
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase